MIFEGEST KIT
Mifepristone 200 MG+Misoprostol 200 MCG
Zydus Pharmaceuticals
It is available in the form of tablet to be taken orally with or without food, only under healthcare provider’s supervision
Normally handled and stored by healthcare providers
Hypersensitivity to Mifepristone, Misoprostolor other prostaglandin Confirmed or suspected ectopic pregnancy Chronic adrenal failure Haemorrhagic disorders or concurrent anticoagulant therapy Inherited porphyria
No Disease Found
Acenocoumarol: May increase the serum concentration of CYP2C9 Substrates Acetohexamide: May enhance the hypoglycemic effect of Hypoglycemic Agents Acetylsalicylic acid: May enhance the hypoglycemic effect of Blood Glucose Lowering Agents Ado-trastuzumab emtansine: May increase the serum concentration of CYP3A4 Substrates Alfentanil: May increase the serum concentration of CYP3A4 Substrates Alfuzosin; May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents Alogliptin; May enhance the hypoglycemic effect of Hypoglycemic Agents Alprazolam: May increase the serum concentration of CYP3A4 Substrates Amantadine: May enhance the QTc-prolonging effect of QTc-Prolonging Agents Aminophylline: May increase the serum concentration of CYP3A4 Substrates
Whether you're looking for a doctor for dealing with your own medical condition, click here to find right physician.
It is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant.